Alpine Immune Sciences Inc
ALPN
ALPN was delisted on the 17th of May, 2024.
50 hedge funds and large institutions have $100M invested in Alpine Immune Sciences Inc in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 4 closing their positions.
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
72% more capital invested
Capital invested by funds: $58.1M → $100M (+$42.1M)
6% more funds holding
Funds holding: 47 → 50 (+3)
27% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$1.25M |
| 2 |
Axa
Paris,
France
|
+$719K |
| 3 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$577K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$572K |
| 5 |
O
OrbiMed
New York
|
+$359K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$2.28M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
-$1.32M |
| 3 |
Jennison Associates
New York
|
-$998K |
| 4 |
AC
Ascend Capital
Orinda,
California
|
-$690K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$316K |
ALPN Hedge Fund Activity: Q3 2016 in Review
50 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Alpine Immune Sciences Inc (ALPN) for Q3 2016, worth a combined $100M — up 72% from $58.1M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new ALPN positions and 4 closed out — a net gain of 3 holders — while 11 added to existing stakes and 15 trimmed.
The largest buyer was Sphera Funds Management, opening a new position worth an estimated $1.25M. The largest seller was Sabby Management, cutting an estimated $2.28M.
- 50 institutional investors held Alpine Immune Sciences Inc (ALPN) as of Q3 2016, up from 47 in Q2 2016.
- Funds reported $100M of Alpine Immune Sciences Inc stock for Q3 2016, up 72% quarter-over-quarter.
- 7 funds opened new Alpine Immune Sciences Inc positions in Q3 2016 and 4 closed out, a net change of +3 holders.
- The largest Alpine Immune Sciences Inc buyer in Q3 2016 was Sphera Funds Management, an estimated $1.25M added.
- The largest Alpine Immune Sciences Inc seller in Q3 2016 was Sabby Management, an estimated $2.28M sold.
Based on aggregated 13F filings for Q3 2016.